RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Everest Medicines Stock

Everest Medicines ROA 2024

Everest Medicines ROA

-0.15

Ticker

1952.HK

ISIN

KYG3224E1061

WKN

A2QD66

In 2024, Everest Medicines's return on assets (ROA) was -0.15, a 291.3% increase from the -0.04 ROA in the previous year.

Everest Medicines Aktienanalyse

What does Everest Medicines do?

Everest Medicines ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Everest Medicines's Return on Assets (ROA)

Everest Medicines's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Everest Medicines's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Everest Medicines's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Everest Medicines’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Everest Medicines stock

What is the Return on Assets (ROA) of Everest Medicines this year?

The Return on Assets (ROA) of Everest Medicines is -0.15 undefined this year.

What was the ROA of Everest Medicines compared to the previous year?

The ROA of Everest Medicines has increased by 291.3% compared to the previous year.

What consequences do high ROA have for investors of Everest Medicines?

A high ROA is advantageous for investors of Everest Medicines, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Everest Medicines?

A low ROA can be unfavorable for investors of Everest Medicines as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Everest Medicines affect the company?

An increase in ROA of Everest Medicines can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Everest Medicines impact the company?

A reduction in the ROA of Everest Medicines can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Everest Medicines?

Some factors that can influence the ROA of Everest Medicines include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Everest Medicines important for investors?

The ROA of Everest Medicines is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Everest Medicines take to improve ROA?

To improve ROA, Everest Medicines can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Everest Medicines pay?

Over the past 12 months, Everest Medicines paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Everest Medicines is expected to pay a dividend of 0 CNY.

What is the dividend yield of Everest Medicines?

The current dividend yield of Everest Medicines is .

When does Everest Medicines pay dividends?

Everest Medicines pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Everest Medicines?

Everest Medicines paid dividends every year for the past 0 years.

What is the dividend of Everest Medicines?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Everest Medicines located?

Everest Medicines is assigned to the 'Health' sector.

Wann musste ich die Aktien von Everest Medicines kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Everest Medicines from 8/10/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 8/10/2024.

When did Everest Medicines pay the last dividend?

The last dividend was paid out on 8/10/2024.

What was the dividend of Everest Medicines in the year 2023?

In the year 2023, Everest Medicines distributed 0 CNY as dividends.

In which currency does Everest Medicines pay out the dividend?

The dividends of Everest Medicines are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Everest Medicines

Our stock analysis for Everest Medicines Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Everest Medicines Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.